Genmab A/s

(OTC) GNMSF

Current Price$258.12

Market Cap$15.36B

Since IPO (2004)+1,496%

5 Year-35%

1 Year+24%

1 Month-5%

Genmab A/s Financials at a Glance

Market Cap

$15.36B

Revenue (TTM)

$8.83B

Net Income (TTM)

$2.61B

EPS (TTM)

$13.21

P/E Ratio

19.35

Dividend

$0.00

Beta (Volatility)

0.36 (Low)

Dividend

$0.00

Beta (Volatility)

0.36 (Low)

Price

$258.12

Volume

Open

$258.12

Price

$258.12

Volume

Open

$258.12

Previous Close

$258.12

Daily Range

$258.12 - $258.12

52-Week Range

$198.51 - $352.00

Dividend

$0.00

Beta (Volatility)

0.36 (Low)

Price

$258.12

Volume

Open

$258.12

Previous Close

$258.12

Daily Range

$258.12 - $258.12

52-Week Range

$198.51 - $352.00

GNMSF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genmab A/s

Industry

Biotechnology

Sector

Health Care

Employees

3,088

CEO

Jan G. J. van de Winkel, PhD

Website

www.genmab.com

Headquarters

Copenhagen, 1560, DK

GNMSF Financials

Key Financial Metrics (TTM)

Gross Margin

94%

Operating Margin

40%

Net Income Margin

18%

Return on Equity

15%

Return on Capital

51%

Return on Assets

21%

Earnings Yield

5.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$15.36B

Shares Outstanding

59.49M

Volume

Avg. Volume

1.90K

Financials (TTM)

Gross Profit

$3.53B

Operating Income

$1.29B

EBITDA

$1.37B

Operating Cash Flow

$1.23B

Capital Expenditure

$38.30M

Free Cash Flow

$1.19B

Cash & ST Invst.

$1.71B

Total Debt

$5.54B

Genmab A/s Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$882.27M

-82.6%

Gross Profit

$818.26M

-82.8%

Gross Margin

92.75%

N/A

Market Cap

$15.36B

N/A

Market Cap/Employee

$5.82M

N/A

Employees

2,638

N/A

Net Income

$52.19M

-96.1%

EBITDA

$221.55M

-87.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$3.83B

-118.0%

Accounts Receivable

$1.03B

-81.3%

Inventory

$21.00M

-74.7%

Long Term Debt

$5.06B

+467.7%

Short Term Debt

$293.01M

+203.0%

Return on Assets

21.14%

N/A

Return on Invested Capital

50.76%

N/A

Free Cash Flow

$1.97M

-100.1%

Operating Cash Flow

$2.95M

-99.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GIKLYGrifols, S.A.

GIKLYGrifols, S.A.$5.30+0.00%

WXXWYWuXi Biologics (Cayman) Inc.

WXXWYWuXi Biologics (Cayman) Inc.$8.29-1.78%

WXIBFWuXi Biologics (Cayman) Inc.

WXIBFWuXi Biologics (Cayman) Inc.$4.18+0.00%

IVBXFInnovent Biologics, Inc.

IVBXFInnovent Biologics, Inc.$10.34-0.08%

SBHMYSino Biopharmaceutical Limited

SBHMYSino Biopharmaceutical Limited$14.29+0.00%

SBMFFSino Biopharmaceutical Limited

SBMFFSino Biopharmaceutical Limited$0.69-0.00%

ORINYOrion Oyj

ORINYOrion Oyj$37.99+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$15.47+0.09%

FFord Motor Company

FFord Motor Company$14.93+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

INTCIntel

INTCIntel$119.84+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

INFQInfleqtion

INFQInfleqtion $16.35+0.11%

Questions About GNMSF

What is the current price of Genmab A/s?

Genmab A/s is trading at $258.12 per share.

What is the 52-week range for Genmab A/s?

Over the past 52 weeks, Genmab A/s has traded between $198.51 and $352.00.

How much debt does Genmab A/s have?

As of the most recent reporting period, Genmab A/s reported total debt of $5.35B.

How much cash does Genmab A/s have on hand?

Genmab A/s reported $1.52B in cash and cash equivalents in its most recent financial results.

What is Genmab A/s’s dividend yield?

Genmab A/s does not currently have a dividend yield.

Genmab A/s

Genmab A/s Financials at a Glance

GNMSF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Genmab A/s

GNMSF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Genmab A/s Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GNMSF

What is the current price of Genmab A/s?

What is the 52-week range for Genmab A/s?

How much debt does Genmab A/s have?

How much cash does Genmab A/s have on hand?

What is Genmab A/s’s dividend yield?

Premium Investing Services